355 related articles for article (PubMed ID: 27989379)
1. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.
Koehler P; Hamprecht A; Bader O; Bekeredjian-Ding I; Buchheidt D; Doelken G; Elias J; Haase G; Hahn-Ast C; Karthaus M; Kekulé A; Keller P; Kiehl M; Krause SW; Krämer C; Neumann S; Rohde H; La Rosée P; Ruhnke M; Schafhausen P; Schalk E; Schulz K; Schwartz S; Silling G; Staib P; Ullmann A; Vergoulidou M; Weber T; Cornely OA; Vehreschild MJ
Int J Antimicrob Agents; 2017 Feb; 49(2):218-223. PubMed ID: 27989379
[TBL] [Abstract][Full Text] [Related]
2. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
[TBL] [Abstract][Full Text] [Related]
3. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany.
Hamprecht A; Buchheidt D; Vehreschild JJ; Cornely OA; Spiess B; Plum G; Halbsguth TV; Kutsch N; Stippel D; Kahl P; Persigehl T; Steinbach A; Bos B; Hallek M; Vehreschild MJ
Euro Surveill; 2012 Sep; 17(36):20262. PubMed ID: 22971327
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
[TBL] [Abstract][Full Text] [Related]
6. Culture-Based Methods and Molecular Tools for Azole-Resistant Aspergillus fumigatus Detection in a Belgian University Hospital.
Montesinos I; Argudín MA; Hites M; Ahajjam F; Dodémont M; Dagyaran C; Bakkali M; Etienne I; Jacobs F; Knoop C; Patteet S; Lagrou K
J Clin Microbiol; 2017 Aug; 55(8):2391-2399. PubMed ID: 28515220
[TBL] [Abstract][Full Text] [Related]
7. Performance of the AsperGenius® PCR assay for detecting azole resistant Aspergillus fumigatus in BAL fluids from allogeneic HSCT recipients: A prospective cohort study from Essen, West Germany.
Pelzer BW; Seufert R; Koldehoff M; Liebregts T; Schmidt D; Buer J; Rath PM; Steinmann J
Med Mycol; 2020 Feb; 58(2):268-271. PubMed ID: 31111913
[TBL] [Abstract][Full Text] [Related]
8. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
9. PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay® in 201 patients with haematological disease suspected for invasive aspergillosis.
Chong GM; van der Beek MT; von dem Borne PA; Boelens J; Steel E; Kampinga GA; Span LF; Lagrou K; Maertens JA; Dingemans GJ; Gaajetaan GR; van Tegelen DW; Cornelissen JJ; Vonk AG; Rijnders BJ
J Antimicrob Chemother; 2016 Dec; 71(12):3528-3535. PubMed ID: 27530755
[TBL] [Abstract][Full Text] [Related]
10. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.
Alanio A; Sitterlé E; Liance M; Farrugia C; Foulet F; Botterel F; Hicheri Y; Cordonnier C; Costa JM; Bretagne S
J Antimicrob Chemother; 2011 Feb; 66(2):371-4. PubMed ID: 21131690
[TBL] [Abstract][Full Text] [Related]
11. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
[TBL] [Abstract][Full Text] [Related]
12. Analytical and Clinical Evaluation of the PathoNostics AsperGenius Assay for Detection of Invasive Aspergillosis and Resistance to Azole Antifungal Drugs Directly from Plasma Samples.
White PL; Posso RB; Barnes RA
J Clin Microbiol; 2017 Aug; 55(8):2356-2366. PubMed ID: 28515217
[TBL] [Abstract][Full Text] [Related]
13. Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.
van Ingen J; van der Lee HA; Rijs TA; Zoll J; Leenstra T; Melchers WJ; Verweij PE
J Antimicrob Chemother; 2015 Jan; 70(1):178-81. PubMed ID: 25301884
[TBL] [Abstract][Full Text] [Related]
14. Prospective multicenter surveillance of clinically isolated Aspergillus species revealed azole-resistant Aspergillus fumigatus isolates with TR34/L98H mutation in the Kyoto and Shiga regions of Japan.
Tsuchido Y; Tanaka M; Nakano S; Yamamoto M; Matsumura Y; Nagao M
Med Mycol; 2019 Nov; 57(8):997-1003. PubMed ID: 30690480
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic strategies for invasive aspergillosis in the era of azole resistance: how should the prevalence of azole resistance be defined?
Alanio A; Denis B; Hamane S; Raffoux E; Peffault de la Tour R; Touratier S; Bergeron A; Bretagne S
J Antimicrob Chemother; 2016 Aug; 71(8):2075-8. PubMed ID: 27494830
[TBL] [Abstract][Full Text] [Related]
16. Airborne Aspergillus fumigatus spore concentration during demolition of a building on a hospital site, and patient risk determination for invasive aspergillosis including azole resistance.
Wirmann L; Ross B; Reimann O; Steinmann J; Rath PM
J Hosp Infect; 2018 Nov; 100(3):e91-e97. PubMed ID: 30056016
[TBL] [Abstract][Full Text] [Related]
17. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
18. Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study.
Huygens S; Dunbar A; Buil JB; Klaassen CHW; Verweij PE; van Dijk K; de Jonge N; Janssen JJWM; van der Velden WJFM; Biemond BJ; Bart A; Bruns AHW; Haas PA; Demandt AMP; Oudhuis G; von dem Borne P; van der Beek MT; Klein SK; Godschalk P; Span LFR; Postma DF; Kampinga GA; Maertens J; Lagrou K; Mercier T; Moors I; Boelens J; Selleslag D; Reynders M; Zandijk W; Doorduijn JK; Cornelissen JJ; Schauwvlieghe AFAD; Rijnders BJA
Clin Infect Dis; 2023 Jul; 77(1):38-45. PubMed ID: 36905147
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and Antifungal Susceptibility Profile of
Cho SY; Lee DG; Kim WB; Chun HS; Park C; Myong JP; Park YJ; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH
J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018982
[TBL] [Abstract][Full Text] [Related]
20. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Snelders E; Melchers WJ; Verweij PE
Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
